Status: current, Defined. Date: 31-Jan 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4665711000168119 | Regkirona (regdanvimab 960 mg / 16 mL) injection, 16 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4665721000168114 | Regkirona 960 mg/16 mL injection, 16 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Regkirona 960 mg/16 mL injection, 16 mL vial | Is a | Regkirona | true | Inferred relationship | Some | ||
| Regkirona 960 mg/16 mL injection, 16 mL vial | Is a | regdanvimab 960 mg/16 mL injection, vial | true | Inferred relationship | Some | ||
| Regkirona 960 mg/16 mL injection, 16 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Regkirona 960 mg/16 mL injection, 16 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Regkirona 960 mg/16 mL injection, 16 mL vial | has Australian BoSS | regdanvimab | true | Inferred relationship | Some | 2050544913 | |
| Regkirona 960 mg/16 mL injection, 16 mL vial | has intended active ingredient | regdanvimab | true | Inferred relationship | Some | 2050544913 | |
| Regkirona 960 mg/16 mL injection, 16 mL vial | has unit of use | vial | true | Inferred relationship | Some | 248731464 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Regkirona 960 mg/16 mL injection, 16 mL vial | has TPUU | True | Regkirona 960 mg/16 mL injection, 16 mL vial | Inferred relationship | Some | 1276735333 |
| Regkirona 960 mg/16 mL injection, 16 mL vial | has TPUU | True | Regkirona 960 mg/16 mL injection, 16 mL vial | Inferred relationship | Some | 1363392036 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR